KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Neogenomics (NEO) over the last 16 years, with Q4 2025 value amounting to $128.1 million.

  • Neogenomics' Shares Outstanding (Weighted Average) rose 113.93% to $128.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $128.1 million, marking a year-over-year increase of 113.93%. This contributed to the annual value of $128.1 million for FY2025, which is 113.93% up from last year.
  • Latest data reveals that Neogenomics reported Shares Outstanding (Weighted Average) of $128.1 million as of Q4 2025, which was up 113.93% from $128.4 million recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' Shares Outstanding (Weighted Average) peaked at $128.4 million during Q3 2025, and registered a low of $116.2 million during Q1 2021.
  • Over the past 5 years, Neogenomics' median Shares Outstanding (Weighted Average) value was $125.4 million (recorded in 2023), while the average stood at $124.6 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 1121.22% in 2021, then surged by 83.68% in 2024.
  • Over the past 5 years, Neogenomics' Shares Outstanding (Weighted Average) (Quarter) stood at $120.0 million in 2021, then grew by 3.55% to $124.2 million in 2022, then rose by 1.03% to $125.5 million in 2023, then rose by 0.92% to $126.7 million in 2024, then increased by 1.14% to $128.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $128.1 million for Q4 2025, versus $128.4 million for Q3 2025 and $127.9 million for Q2 2025.